Lindbrook Capital’s Aehr Test Systems AEHR Stock Holding History

Lindbrook Capital’s Portfolio AEHR Stock Details AEHR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-11	Closed	-$183	–	2783
2024 Q4	$183	Buy	+11	New	+$147	﹤0.01%	2717

Other funds holding AEHR

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

AIC

AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

RHJA

Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

HFF

Halter Ferguson Financial Carmel, Indiana $617M AUM 69.99% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Lindbrook Capital's AEHR Position: Q1 2025 in Review

Lindbrook Capital sold out of Aehr Test Systems (AEHR) in Q1 2025, closing a stake of 11 shares — an estimated $183 sold.

Lindbrook Capital first reported a position in AEHR in Q4 2024 and held it in 1 quarter. The position peaked at $183 in Q4 2024. 115 funds tracked by Wall St. Rank hold AEHR as of Q1 2025.

Lindbrook Capital reported no remaining Aehr Test Systems position as of Q1 2025 after selling out during the quarter.
Lindbrook Capital sold 11 Aehr Test Systems shares in Q1 2025, an estimated $183.
Lindbrook Capital first reported a position in Aehr Test Systems in Q4 2024 and held it in 1 quarter.
Lindbrook Capital's Aehr Test Systems position peaked at $183 in Q4 2024.
115 funds tracked by Wall St. Rank held Aehr Test Systems as of Q1 2025.

Based on Lindbrook Capital's 13F filing for Q1 2025, filed 5 May 2025.